Diabetes Mellitus and Metabolic Profile in Long‐Term Survivors of Wilms Tumor: A Nationwide Cohort Study With Sibling Controls
Pediatric Blood & Cancer · 2026
DOI: 10.1002/pbc.32097 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Stine Høgsholt und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: Wilms Tumor, Siblings, Kidney Neoplasms, Cancer Survivors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
As survival after Wilms tumor has markedly improved, focus on potential long‐term consequences is necessary. We investigated the metabolic profile among Danish survivors of Wilms tumor >20 years from cancer diagnosis.
Methods
As of January 15, 2015, we established a cohort of 20‐plus‐year survivors of Wilms tumor identified through the national cancer registries. Siblings contributed as controls. Participation included clinical examination with anthropometric measurements, blood samples, blood pressure measurements, and a comprehensive health questionnaire. Using logistic regression, we identified risk factors for diabetes mellitus (DM).
Results
With a response rate of 64%, we included 99 survivors of Wilms tumor with a median of 37 years since diagnosis (median age of 41, range: 24–70), and 38 sibling controls (median age of 41, range: 24–66). An increased prevalence of DM was found in the survivors as compared with their siblings (15% vs. 0%). A logistic regression analysis adjusted for age at follow‐up showed that left‐sided versus right‐sided abdominal radiation therapy was a risk factor for the development of DM (odds ratio [OR] 7.9, 95% confidence interval [CI]: 1.4–44). A larger fraction of the survivors was in active treatment for hypertension compared to siblings (42% vs. 37%), but with no significant difference in body mass index, hip, or waist circumferences. Furthermore, Wilms tumor survivors were more likely to be in active treatment with lipid‐lowering agents (8% vs. 3%).
Conclusion
Left‐sided abdominal radiation is a major risk factor for DM in long‐term survivors of Wilms tumor. Patients may benefit from surveillance with increased focus on metabolic risk profile to decrease the risk of DM and cardiovascular events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark.
- Department of Endocrinology, Aarhus University Hospital, Aarhus, Denmark.
- Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
- Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
- Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
ORCID-Profile: Stine Høgsholt, Henrik Hasle
Zitieren
APA
Høgsholt, S., Stochholm, K., Søndergaard, E., Asdahl, P. H., Rechnitzer, C., & Hasle, H. (2026). Diabetes Mellitus and Metabolic Profile in Long‐Term Survivors of Wilms Tumor: A Nationwide Cohort Study With Sibling Controls. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.32097
Vancouver
Høgsholt S, Stochholm K, Søndergaard E, Asdahl PH, Rechnitzer C, Hasle H. Diabetes Mellitus and Metabolic Profile in Long‐Term Survivors of Wilms Tumor: A Nationwide Cohort Study With Sibling Controls. Pediatric Blood & Cancer. 2026. doi:10.1002/pbc.32097
BibTeX
@article{Hgsholt2026,
author = {Høgsholt, Stine and Stochholm, Kirstine and Søndergaard, Esben and Asdahl, Peter Haubjerg and Rechnitzer, Catherine and Hasle, Henrik},
title = {Diabetes Mellitus and Metabolic Profile in Long‐Term Survivors of Wilms Tumor: A Nationwide Cohort Study With Sibling Controls},
journal = {Pediatric Blood & Cancer},
year = {2026},
doi = {10.1002/pbc.32097}
}
EUVIMED